pharmaceutical investing Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat
pharmaceutical investing FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher
Apple introduces MacBook Pro with all-new M5 Pro and M5 Max, delivering breakthrough pro performance and next-level on-device AI
